WCN25-3026 USE OF EMPIRICAL DEFLAZACORT TO PRESERVE KIDNEY FUNCTION AND DELAY ONSET OF RENAL REPLACEMENT THERAPY IN PATIENTS WITH CKD OF UNKNOWN ETIOLOGY

Chronic kidney disease (CKD) represents a global public health problem. Over 90% of patients requiring renal replacement therapy (RRT) in India die because of inability to afford care, and even in those who do start RRT, 60% stop for financial reasons. In some cases of CKD, the etiology has been established, while it remains unexplained in many parts of the world, being therefore termed chronic kidney disease of unknown origin (CKDu) or alternatively chronic interstitial nephritis in developing countries.